JPWO2024029242A1 - - Google Patents
Info
- Publication number
- JPWO2024029242A1 JPWO2024029242A1 JP2024538862A JP2024538862A JPWO2024029242A1 JP WO2024029242 A1 JPWO2024029242 A1 JP WO2024029242A1 JP 2024538862 A JP2024538862 A JP 2024538862A JP 2024538862 A JP2024538862 A JP 2024538862A JP WO2024029242 A1 JPWO2024029242 A1 JP WO2024029242A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025061336A JP2025102922A (ja) | 2022-08-05 | 2025-04-02 | 新規ｌｒｐ１結合ペプチド |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022125238 | 2022-08-05 | ||
| JP2022125238 | 2022-08-05 | ||
| PCT/JP2023/024137 WO2024029242A1 (ja) | 2022-08-05 | 2023-06-29 | 新規ｌｒｐ１結合ペプチド |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025061336A Division JP2025102922A (ja) | 2022-08-05 | 2025-04-02 | 新規ｌｒｐ１結合ペプチド |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2024029242A1 true JPWO2024029242A1 (https=) | 2024-02-08 |
| JPWO2024029242A5 JPWO2024029242A5 (https=) | 2024-10-08 |
| JP7665261B2 JP7665261B2 (ja) | 2025-04-21 |
Family
ID=89848802
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024538862A Active JP7665261B2 (ja) | 2022-08-05 | 2023-06-29 | 新規ｌｒｐ１結合ペプチド |
| JP2025061336A Pending JP2025102922A (ja) | 2022-08-05 | 2025-04-02 | 新規ｌｒｐ１結合ペプチド |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025061336A Pending JP2025102922A (ja) | 2022-08-05 | 2025-04-02 | 新規ｌｒｐ１結合ペプチド |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP4541891A1 (https=) |
| JP (2) | JP7665261B2 (https=) |
| CN (1) | CN119630790A (https=) |
| WO (1) | WO2024029242A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7713129B1 (ja) * | 2023-12-28 | 2025-07-24 | 一丸ファルコス株式会社 | 組成物 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015526434A (ja) * | 2012-08-14 | 2015-09-10 | アンジオケム インコーポレーテッド | ペプチド−デンドリマーコンジュゲート及びその使用 |
| JP2022033027A (ja) * | 2020-08-11 | 2022-02-25 | アプライド マテリアルズ イスラエル リミテッド | ウエハ分析のための較正データを生成する方法およびシステム |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7110800B2 (ja) | 2018-07-31 | 2022-08-02 | 株式会社三洋物産 | 遊技機 |
| CA3128035A1 (en) * | 2020-08-13 | 2022-02-13 | Bioasis Technologies, Inc. | Combination therapies for delivery across the blood brain barrier |
-
2023
- 2023-06-29 CN CN202380056691.4A patent/CN119630790A/zh active Pending
- 2023-06-29 JP JP2024538862A patent/JP7665261B2/ja active Active
- 2023-06-29 EP EP23849801.8A patent/EP4541891A1/en active Pending
- 2023-06-29 WO PCT/JP2023/024137 patent/WO2024029242A1/ja not_active Ceased
-
2025
- 2025-04-02 JP JP2025061336A patent/JP2025102922A/ja active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015526434A (ja) * | 2012-08-14 | 2015-09-10 | アンジオケム インコーポレーテッド | ペプチド−デンドリマーコンジュゲート及びその使用 |
| JP2022033027A (ja) * | 2020-08-11 | 2022-02-25 | アプライド マテリアルズ イスラエル リミテッド | ウエハ分析のための較正データを生成する方法およびシステム |
Non-Patent Citations (3)
| Title |
|---|
| ANDRE SEVERINE ET AL.: "Development of an LDL Receptor-Targeted Peptide Susceptible to Facilitate the Brain Access of Diagno", BIOLOGY, vol. 9, JPN6023037283, 2020, pages 161, ISSN: 0005459554 * |
| RUAN HUITONG ET AL.: "Stapled RAP12 peptide ligand of LRP1 for micelles-based multifunctional glioma-targeted drug deliver", CHEMICAL ENGINEERING JOURNAL, vol. 403, JPN6023037284, 2021, pages 126296, ISSN: 0005459553 * |
| SAKAMOTO KOTARO: "Generation of KS-487 as a novel LRP1-binding cyclic peptide with higher affinity, higher stability a", BIOCHEMISTRY AND BIOPHYSICS REPORTS, vol. 32, JPN6023037282, 8 October 2022 (2022-10-08), pages 101367, ISSN: 0005459555 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP4541891A1 (en) | 2025-04-23 |
| JP7665261B2 (ja) | 2025-04-21 |
| WO2024029242A1 (ja) | 2024-02-08 |
| JP2025102922A (ja) | 2025-07-08 |
| CN119630790A (zh) | 2025-03-14 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240724 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240724 |
|
| A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20240724 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20241112 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20241219 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20250304 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20250402 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7665261 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |